Chimerism in Myeloid Malignancies following Stem Cell Transplantation Using FluBu4 with and without Busulfan Pharmacokinetics versus BuCy

Table 2

Total donor chimerism on day 30.

Chimerism results at day 30				P value
	FluBu4 with PK	FluBu4 with no PK	BuCy
100% donor	14	17	16	.311
86%–99%	7	15	5
<85%	0	2	2

Bu, busulfan; Cy, cyclophosphamide; Flu, fludarabine; PK, pharmacokinetics.